Lithium and Lamotrigine Do Not Increase Prolactin Levels
Neither lithium nor lamotrigine cause clinically significant increases in serum prolactin levels; in fact, lithium may actually lower prolactin levels with long-term use.
Evidence for Lithium
The Endocrine Society Clinical Practice Guideline 1 extensively discusses medication-induced hyperprolactinemia but notably does not list lithium among the medications that cause this condition. The guideline specifically identifies antipsychotics (typical and atypical), metoclopramide, verapamil, opiates, and estrogen-containing contraceptives as prolactin-elevating agents, but lithium is conspicuously absent from this comprehensive list.
Research evidence supports lithium's neutral-to-beneficial effect on prolactin:
Long-term lithium treatment (>6 months) actually lowers prolactin levels compared to controls 2. In a study of euthymic bipolar patients, those on long-term lithium had significantly lower serum prolactin than healthy controls, while short-term treatment (<6 months) showed no significant difference.
A systematic review of bipolar disorder medications found that lithium was reported to lower prolactin levels in some studies 3, making it one of the safer options regarding prolactin effects.
One case report 4 suggested lithium-induced hyperprolactinemia, but this represents an isolated finding contradicting the broader evidence base and should be viewed as a rare exception rather than the rule.
Mechanism Considerations
While lithium can enhance serotonin-mediated prolactin release in experimental settings 5, 6, this pharmacological effect does not translate into clinically significant hyperprolactinemia in real-world use. The FDA drug label for lithium 7 does not list hyperprolactinemia or prolactin elevation among its adverse reactions.
Evidence for Lamotrigine
Lamotrigine does not cause hyperprolactinemia. The Endocrine Society guideline [1-1] does not mention lamotrigine as a prolactin-elevating medication.
Research findings:
In women with epilepsy, lamotrigine was associated with lower follicle-stimulating hormone levels but not with prolactin elevation 8. The study found no difference in prolactin levels between women with epilepsy (many on lamotrigine) and controls.
Lamotrigine's hormonal effects relate primarily to estradiol interactions affecting drug clearance 9, not prolactin secretion.
Clinical Implications
If a patient on lithium or lamotrigine develops hyperprolactinemia:
- Do not attribute it to these medications - look for other causes
- Check for concurrent antipsychotic use (risperidone, paliperidone, typical antipsychotics cause hyperprolactinemia in 40-100% of patients 1)
- Evaluate for metoclopramide, verapamil, or other dopamine antagonists
- Consider pituitary imaging if no medication cause is identified and symptoms are present 1
Common Pitfall to Avoid
Do not discontinue lithium or lamotrigine based on hyperprolactinemia concerns. These medications are effective mood stabilizers 10 and do not cause this endocrine complication. Stopping them unnecessarily risks psychiatric destabilization while failing to address the true cause of elevated prolactin.